Literature DB >> 8908056

Effect of CMV serology on outcome after clinical intestinal transplantation.

H Furukawa1, S Kusne, K Abu-Elmagd, M Green, J Reyes, T E Starzl, S Todo.   

Abstract

Mesh:

Substances:

Year:  1996        PMID: 8908056      PMCID: PMC2956492     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  CMV infection, class II antigen expression, and human kidney allograft rejection.

Authors:  E von Willebrand; E Pettersson; J Ahonen; P Häyry
Journal:  Transplantation       Date:  1986-10       Impact factor: 4.939

2.  Cytomegalovirus disease in intestinal transplantation.

Authors:  H Furukawa; R Manez; S Kusne; K Abu-Elmagd; M Green; G Reyes; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

3.  Technical aspects of intestinal transplantation.

Authors:  H Furukawa; K Abu-Elmagd; J Reyes; B Nour; A Tzakis; S Todo; T E Starzl
Journal:  Surg Technol Int       Date:  1993-10

4.  Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation.

Authors:  R Mañez; S Kusne; M Green; K Abu-Elmagd; W Irish; J Reyes; H Furukawa; A Tzakis; J J Fung; S Todo
Journal:  Transplantation       Date:  1995-04-15       Impact factor: 4.939

5.  Outcome analysis of 71 clinical intestinal transplantations.

Authors:  S Todo; J Reyes; H Furukawa; K Abu-Elmagd; R G Lee; A Tzakis; A S Rao; T E Starzl
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

  5 in total
  1 in total

Review 1.  Viral prophylaxis in organ transplant patients.

Authors:  Michelle Slifkin; Shira Doron; David R Snydman
Journal:  Drugs       Date:  2004       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.